Maintaining the voice of rare diseases in a new, virtual world: Insights from the European Conference on Rare Diseases (ECRD) 2020

Rare disease diagnosis remains a key challenge

Can we drive a change in perceptions and attitudes by reframing rare diseases and stressing the importance of patient groups?

Alpharmaxim work closely with industry to raise awareness of rare diseases, developing educational materials and resources for healthcare professionals and helping to bring rare diseases into the spotlight.

  • There is an important need for physicians to understand the relevance of rare diseases within their clinical career and to consider rare diseases when the clinical picture doesn’t provide all the answers
  • Further education around genetics and rare diseases for medical students is needed
  • Very few general practitioners have access to rare disease-specific internet resources such as Orphanet; there is limited information regarding when to consider a rare disease and what to do when you come across one in clinical practice

Be prepared to truly demonstrate your commitment to the rare disease field, particularly in these uncertain times.

At Alpharmaxim, we have extensive experience in helping speciality healthcare companies across the world communicate with HCPs and patients, particularly in rare diseases. We are passionate about helping our clients tell their stories and fulfil their promises, and we aim to make a real difference to patients, families and healthcare professionals.

If you would like to know more, contact Sophie Jones on +44 (0)161 929 0400.

CEO, Chief Executive Officer; ECRD, European Conference on Rare Diseases; GP, general practitioner; HCP, healthcare professional; TLC, The Leukodystrophy Charity